Cash Flow

v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Operating Activities:      
Net loss $ (54,568) $ (71,658) $ (40,703)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization 1,498 997 988
Amortization of premium (discount) on marketable securities (673) 221 827
Net loss on disposal of property and equipment 12    
Stock-based compensation 9,089 15,057 11,730
Change in fair value of contingent consideration liability     (1,800)
Intangible impairment     1,870
Benefit from income taxes   (14) (5,722)
Other 80 99  
Net changes in operating assets and liabilities:      
Interest receivable (16) 83 116
Accounts receivable 1,629 (2,144) 7,847
Prepaid expenses and other assets (669) (1,112) 376
Accounts payable and accrued liabilities 3,219 (2,335) (764)
Accrued compensation and employee benefits 2,594 137 (105)
Deferred revenues 48,984 (5,214) (8,380)
Net cash provided by (used in) operating activities 11,179 (65,883) (33,720)
Investing Activities:      
Purchases of marketable securities (252,328) (218,640) (257,988)
Maturities of marketable securities 178,675 237,497 337,861
Purchases of property and equipment (3,751) (732)  
Lease commitments (3,500)    
Acquisition of Ceregene, Inc. net of cash received     (2,411)
Net cash (used in) provided by investing activities (80,904) 18,125 77,462
Financing Activities:      
Proceeds from public offering of common stock, net of issuance costs 81,573    
Taxes paid related to net share settlement of equity awards (654) (776) (1,546)
Proceeds from issuance of common stock 16,571 1,113 6,804
Claims settlement under Section 16(b)     14,452
Net cash provided by financing activities 97,490 337 19,710
Net increase (decrease) in cash and cash equivalents 27,765 (47,421) 63,452
Cash and cash equivalents, beginning of period 22,061 69,482 6,030
Cash and cash equivalents, end of period 49,826 22,061 $ 69,482
Property and Equipment [Member]      
Supplemental disclosure of noncash investing activities:      
Property and equipment/build-to-suit leases included in accrued liabilities and obligation 1,214    
Build-to-Suit Leases [Member]      
Supplemental disclosure of noncash investing activities:      
Property and equipment/build-to-suit leases included in accrued liabilities and obligation $ 20,793 $ 3,876  

Source

Sign Up For E-Mail Alerts

Sign Up